NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
Kineta Inc.
National Cancer Institute, Naples
University College, London
Saitama Medical University International Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano